Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Patients With Rectal Cancer: A Prospective, Single-center, Single-arm, Open-label Clinical Study

NCT07711509 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07711509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07711509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Patients With Rectal Cancer: A Prospective, Single-center, Single-arm, Open-label Clinical Study
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 25, 2025
Completion date
September 1, 2026
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diversion colitis, fecal incontinence, gut microbiota dysbiosis, ileostomy, low anterior resection syndrome, rectal cancer